Trending News Today: Antitrust Suit Filed Against Biologic Manufacturer Over Biosimilar Practices
Top news of the day from across the health care landscape.
Last week, officials reported that enrollment in Affordable Care Act (ACA) plans for 2018 nearly reached 2017’s numbers in half the amount of time, according to
Pfizer recently filed an antitrust lawsuit against Janssen Biotech over the emergence of an infliximab (Remicade) biosimilar,
House GOP leaders included $2.85 billion for the Children’s Health Insurance Program (CHIP) in a stop-gap funding bill as effort to prevent government shutdown, according to
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Related Articles
- Effectively Managing Immunizations in the Long-Term Care Setting
September 18th 2025
- Creating a Culture of Quality in Fast-Melt Tablet Development
September 18th 2025
- Advise Patients About Self-Care Measures to Treat Mild to Moderate GI Issues
September 18th 2025